scispace - formally typeset
J

John M. Pezzuto

Researcher at Long Island University

Publications -  599
Citations -  38474

John M. Pezzuto is an academic researcher from Long Island University. The author has contributed to research in topics: Cancer & Resveratrol. The author has an hindex of 88, co-authored 588 publications receiving 35901 citations. Previous affiliations of John M. Pezzuto include Purdue University & Bandung Institute of Technology.

Papers
More filters
Journal ArticleDOI

Natural modulators of estrogen biosynthesis and function as chemopreventive agents.

TL;DR: Some agents currently in use or under development for treatment or prevention of breast cancer, as well as strategies for the discovery of natural product modulators of estrogen biosynthesis and function are described.
Journal ArticleDOI

Resveratrol: a whiff that induces a biologically specific tsunami.

TL;DR: Commentary to: Effects of Resveratrol on Gene Expression in Renal Cell Carcinoma Ting Shi, Louis S. Liou, Provash Sadhukhan, Zhong-Hui Duan, Andrew C. Novick, John G. Hissong, Alexandru Almasan and Joseph A. DiDonato
Journal ArticleDOI

Constituents of the seeds of Hernandia ovigera with inhibitory activity against cyclooxygenase-2.

TL;DR: A new dibenzylbutyrolactone lignan, (2 R,3 R)-5'-methoxyguayarol (1), was isolated from an EtOAc-soluble extract of the seeds of Hernandia ovigera using an in vitro activity-guided fractionation procedure based on the inhibition of cyclooxygenase-2.
Journal ArticleDOI

Neoflavonoids and tetrahydroquinolones as possible cancer chemopreventive agents.

TL;DR: Investigation into the actions of neoflavonoids and tetrahydroquinolones, especially those related to the NFκB signaling pathway, aromatase inhibition, induction of quinone reductase 1 expression, and in vivo studies could provide new insights into the cancer chemopreventive ability of these molecules.
Journal ArticleDOI

Evaluation of the mutagenic potential of endod (Phytolacca dodecandra), a molluscicide of potential value for the control of schistosomiasis.

TL;DR: Subject to the results of future safety assessment, endod remains a viable candidate as a useful molluscicide.